ANGO · AngioDynamics, Inc.
AI read · Neutral
The AI's read
His years in medical-device leadership give him relevant experience for the role. The filing does not say that his appointment changes AngioDynamics' sales, products, or plans. The agreement includes a $735,000 yearly salary, a bonus target of 95% of salary, stock awards, and a $350,000 cash sign-on payment. Those are added costs for the company. Clemmer's planned retirement was not tied to a disagreement with the company. The leadership experience is encouraging, but the added pay and lack of reported business changes leave the company's outlook unchanged.